Clinical Trial Results TV
February 22, 2006: PCI for Cardiogenic Shock: Lessons and Advances
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Percutaneous Coronary Intervention for Cardiogenic Shock: Lessons and Advances
* Case Presentation
* Percutaneous Coronary Intervention for Cardiogenic Shock: Lessons and Advances
* CS in 2006: New Lessons
* Incidence of CS: Constant
* Why Haven t We Reduced Incidence of CS?
* Constant CS: Creating High-risk Situations
* Is CS Iatrogenic? COMMIT STEMI Trial
* CS Mortality: Still High After SHOCK?
* CS: Good News 87% of 1-yr Survivors Are NYHA I/II

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest, Harold Dauerman, MD, serves as a consultant for Arginox Pharmaceuticals. Dr.
Dauerman also receives research grants from or is an advisory board member for Arginox,
Genentech, Boston Scientific, and Guidant.



PCI for Cardiogenic Shock: Lessons and Advances

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-18-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted